nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioproperazine—HTR2A—conduct disorder	0.899	1	CbGaD
Thioproperazine—DRD1—Dopamine receptors—DRD4—conduct disorder	0.00881	0.0969	CbGpPWpGaD
Thioproperazine—DRD2—Dopamine receptors—DRD4—conduct disorder	0.00665	0.0732	CbGpPWpGaD
Thioproperazine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.00389	0.0428	CbGpPWpGaD
Thioproperazine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.00386	0.0425	CbGpPWpGaD
Thioproperazine—HTR1A—Serotonin receptors—HTR2A—conduct disorder	0.00245	0.027	CbGpPWpGaD
Thioproperazine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.00211	0.0232	CbGpPWpGaD
Thioproperazine—SLC22A1—Norepinephrine Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00202	0.0222	CbGpPWpGaD
Thioproperazine—DRD1—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.002	0.022	CbGpPWpGaD
Thioproperazine—DRD1—Monoamine GPCRs—DRD4—conduct disorder	0.00195	0.0214	CbGpPWpGaD
Thioproperazine—HTR1A—Monoamine GPCRs—DRD4—conduct disorder	0.00167	0.0184	CbGpPWpGaD
Thioproperazine—DRD1—Amine ligand-binding receptors—DRD4—conduct disorder	0.00164	0.018	CbGpPWpGaD
Thioproperazine—ADRA1B—Monoamine GPCRs—DRD4—conduct disorder	0.00159	0.0175	CbGpPWpGaD
Thioproperazine—DRD2—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.00151	0.0166	CbGpPWpGaD
Thioproperazine—DRD2—Monoamine GPCRs—DRD4—conduct disorder	0.00147	0.0162	CbGpPWpGaD
Thioproperazine—HTR2A—Monoamine GPCRs—DRD4—conduct disorder	0.00145	0.0159	CbGpPWpGaD
Thioproperazine—ADRA1A—Monoamine GPCRs—DRD4—conduct disorder	0.00142	0.0156	CbGpPWpGaD
Thioproperazine—HTR1A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00141	0.0155	CbGpPWpGaD
Thioproperazine—ADRA1B—Amine ligand-binding receptors—DRD4—conduct disorder	0.00134	0.0147	CbGpPWpGaD
Thioproperazine—DRD1—Monoamine GPCRs—HTR2A—conduct disorder	0.00127	0.014	CbGpPWpGaD
Thioproperazine—DRD2—Amine ligand-binding receptors—DRD4—conduct disorder	0.00124	0.0136	CbGpPWpGaD
Thioproperazine—HTR2A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00122	0.0134	CbGpPWpGaD
Thioproperazine—DRD1—G alpha (s) signalling events—CGA—conduct disorder	0.00121	0.0133	CbGpPWpGaD
Thioproperazine—ADRA1A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00119	0.0131	CbGpPWpGaD
Thioproperazine—HTR1A—Monoamine GPCRs—HTR2A—conduct disorder	0.00109	0.012	CbGpPWpGaD
Thioproperazine—DRD1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00107	0.0117	CbGpPWpGaD
Thioproperazine—ADRA1B—Monoamine GPCRs—HTR2A—conduct disorder	0.00104	0.0114	CbGpPWpGaD
Thioproperazine—SLC22A1—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00102	0.0113	CbGpPWpGaD
Thioproperazine—DRD2—Monoamine GPCRs—HTR2A—conduct disorder	0.000959	0.0106	CbGpPWpGaD
Thioproperazine—ADRA1A—Monoamine GPCRs—HTR2A—conduct disorder	0.000924	0.0102	CbGpPWpGaD
Thioproperazine—HTR1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000919	0.0101	CbGpPWpGaD
Thioproperazine—ADRA1B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000875	0.00962	CbGpPWpGaD
Thioproperazine—DRD2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000806	0.00887	CbGpPWpGaD
Thioproperazine—ADRA1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000777	0.00854	CbGpPWpGaD
Thioproperazine—HTR2A—GPCRs, Other—DRD4—conduct disorder	0.000643	0.00707	CbGpPWpGaD
Thioproperazine—Propiomazine—DRD4—conduct disorder	0.000617	0.0615	CrCbGaD
Thioproperazine—SLC22A1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000615	0.00677	CbGpPWpGaD
Thioproperazine—DRD1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000575	0.00632	CbGpPWpGaD
Thioproperazine—Cyamemazine—HTR2A—conduct disorder	0.000553	0.0552	CrCbGaD
Thioproperazine—Methotrimeprazine—DRD4—conduct disorder	0.000527	0.0526	CrCbGaD
Thioproperazine—HTR1A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000514	0.00565	CbGpPWpGaD
Thioproperazine—Nefazodone—SLC6A4—conduct disorder	0.000513	0.0512	CrCbGaD
Thioproperazine—Quetiapine—DRD4—conduct disorder	0.000497	0.0495	CrCbGaD
Thioproperazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000494	0.00544	CbGpPWpGaD
Thioproperazine—DRD1—Circadian rythm related genes—SLC6A4—conduct disorder	0.000488	0.00537	CbGpPWpGaD
Thioproperazine—Trazodone—SLC6A4—conduct disorder	0.000475	0.0473	CrCbGaD
Thioproperazine—SLC22A1—Neuronal System—GABRA2—conduct disorder	0.000471	0.00518	CbGpPWpGaD
Thioproperazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000471	0.00518	CbGpPWpGaD
Thioproperazine—DRD1—Circadian rythm related genes—DRD4—conduct disorder	0.000459	0.00505	CbGpPWpGaD
Thioproperazine—Promazine—DRD4—conduct disorder	0.000457	0.0455	CrCbGaD
Thioproperazine—HTR2A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000444	0.00488	CbGpPWpGaD
Thioproperazine—DRD1—GPCR ligand binding—CGA—conduct disorder	0.000438	0.00482	CbGpPWpGaD
Thioproperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000434	0.00477	CbGpPWpGaD
Thioproperazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000427	0.0047	CbGpPWpGaD
Thioproperazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000418	0.0046	CbGpPWpGaD
Thioproperazine—Chlorpromazine—DRD4—conduct disorder	0.000402	0.0401	CrCbGaD
Thioproperazine—Zuclopenthixol—HTR2A—conduct disorder	0.000397	0.0395	CrCbGaD
Thioproperazine—Nefazodone—HTR2A—conduct disorder	0.000394	0.0393	CrCbGaD
Thioproperazine—HTR1A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000387	0.00425	CbGpPWpGaD
Thioproperazine—HTR1A—GPCR ligand binding—CGA—conduct disorder	0.000377	0.00414	CbGpPWpGaD
Thioproperazine—DRD1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000376	0.00413	CbGpPWpGaD
Thioproperazine—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.000369	0.00405	CbGpPWpGaD
Thioproperazine—Trazodone—HTR2A—conduct disorder	0.000365	0.0364	CrCbGaD
Thioproperazine—ADRA1B—GPCR ligand binding—CGA—conduct disorder	0.000359	0.00394	CbGpPWpGaD
Thioproperazine—Acepromazine—HTR2A—conduct disorder	0.000356	0.0355	CrCbGaD
Thioproperazine—Clomipramine—SLC6A4—conduct disorder	0.000352	0.0351	CrCbGaD
Thioproperazine—HTR1A—G alpha (i) signalling events—DRD4—conduct disorder	0.000348	0.00383	CbGpPWpGaD
Thioproperazine—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.000346	0.00381	CbGpPWpGaD
Thioproperazine—Pipotiazine—HTR2A—conduct disorder	0.000342	0.0341	CrCbGaD
Thioproperazine—Thiothixene—HTR2A—conduct disorder	0.000342	0.0341	CrCbGaD
Thioproperazine—Mesoridazine—HTR2A—conduct disorder	0.000337	0.0336	CrCbGaD
Thioproperazine—HTR2A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000334	0.00368	CbGpPWpGaD
Thioproperazine—DRD2—GPCR ligand binding—CGA—conduct disorder	0.000331	0.00364	CbGpPWpGaD
Thioproperazine—HTR2A—GPCR ligand binding—CGA—conduct disorder	0.000325	0.00358	CbGpPWpGaD
Thioproperazine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000323	0.00355	CbGpPWpGaD
Thioproperazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000322	0.00354	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR ligand binding—CGA—conduct disorder	0.000319	0.0035	CbGpPWpGaD
Thioproperazine—HTR1A—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000315	0.00347	CbGpPWpGaD
Thioproperazine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000308	0.00338	CbGpPWpGaD
Thioproperazine—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.000306	0.00336	CbGpPWpGaD
Thioproperazine—SLC22A1—Transmission across Chemical Synapses—COMT—conduct disorder	0.000296	0.00326	CbGpPWpGaD
Thioproperazine—Fluphenazine—HTR2A—conduct disorder	0.000296	0.0295	CrCbGaD
Thioproperazine—SLC22A1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000294	0.00323	CbGpPWpGaD
Thioproperazine—Propiomazine—HTR2A—conduct disorder	0.000284	0.0283	CrCbGaD
Thioproperazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000284	0.00312	CbGpPWpGaD
Thioproperazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000279	0.00307	CbGpPWpGaD
Thioproperazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000277	0.00305	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000273	0.00301	CbGpPWpGaD
Thioproperazine—Clomipramine—HTR2A—conduct disorder	0.00027	0.0269	CrCbGaD
Thioproperazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000264	0.0029	CbGpPWpGaD
Thioproperazine—ADRA1B—G alpha (q) signalling events—HTR2A—conduct disorder	0.00026	0.00286	CbGpPWpGaD
Thioproperazine—Thioridazine—HTR2A—conduct disorder	0.000255	0.0254	CrCbGaD
Thioproperazine—SLC22A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000253	0.00279	CbGpPWpGaD
Thioproperazine—DRD1—GPCR downstream signaling—CGA—conduct disorder	0.000247	0.00272	CbGpPWpGaD
Thioproperazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000245	0.0027	CbGpPWpGaD
Thioproperazine—DRD1—GPCR ligand binding—DRD4—conduct disorder	0.000245	0.0027	CbGpPWpGaD
Thioproperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000243	0.00267	CbGpPWpGaD
Thioproperazine—Methotrimeprazine—HTR2A—conduct disorder	0.000243	0.0242	CrCbGaD
Thioproperazine—Imipramine—SLC6A4—conduct disorder	0.00024	0.0239	CrCbGaD
Thioproperazine—Promethazine—HTR2A—conduct disorder	0.000239	0.0239	CrCbGaD
Thioproperazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000239	0.00263	CbGpPWpGaD
Thioproperazine—Trifluoperazine—HTR2A—conduct disorder	0.000236	0.0236	CrCbGaD
Thioproperazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000234	0.00258	CbGpPWpGaD
Thioproperazine—Perphenazine—HTR2A—conduct disorder	0.000234	0.0233	CrCbGaD
Thioproperazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000232	0.00256	CbGpPWpGaD
Thioproperazine—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.000231	0.00254	CbGpPWpGaD
Thioproperazine—Quetiapine—HTR2A—conduct disorder	0.000229	0.0228	CrCbGaD
Thioproperazine—SLC22A1—Neuronal System—COMT—conduct disorder	0.000227	0.0025	CbGpPWpGaD
Thioproperazine—SLC22A1—Neuronal System—MAOA—conduct disorder	0.000225	0.00248	CbGpPWpGaD
Thioproperazine—DRD1—Signaling by GPCR—CGA—conduct disorder	0.000225	0.00247	CbGpPWpGaD
Thioproperazine—HTR1A—GPCR downstream signaling—CGA—conduct disorder	0.000213	0.00234	CbGpPWpGaD
Thioproperazine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000211	0.00232	CbGpPWpGaD
Thioproperazine—HTR1A—GPCR ligand binding—DRD4—conduct disorder	0.000211	0.00232	CbGpPWpGaD
Thioproperazine—Promazine—HTR2A—conduct disorder	0.000211	0.021	CrCbGaD
Thioproperazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00021	0.00231	CbGpPWpGaD
Thioproperazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000206	0.00227	CbGpPWpGaD
Thioproperazine—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	0.000203	0.00223	CbGpPWpGaD
Thioproperazine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000201	0.00221	CbGpPWpGaD
Thioproperazine—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	0.000201	0.00221	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling by GPCR—CGA—conduct disorder	0.000193	0.00212	CbGpPWpGaD
Thioproperazine—ALB—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00019	0.00209	CbGpPWpGaD
Thioproperazine—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.000187	0.00205	CbGpPWpGaD
Thioproperazine—Chlorpromazine—HTR2A—conduct disorder	0.000185	0.0185	CrCbGaD
Thioproperazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000185	0.00204	CbGpPWpGaD
Thioproperazine—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.000185	0.00204	CbGpPWpGaD
Thioproperazine—Imipramine—HTR2A—conduct disorder	0.000184	0.0184	CrCbGaD
Thioproperazine—ADRA1B—Signaling by GPCR—CGA—conduct disorder	0.000184	0.00202	CbGpPWpGaD
Thioproperazine—HTR2A—GPCR downstream signaling—CGA—conduct disorder	0.000184	0.00202	CbGpPWpGaD
Thioproperazine—HTR2A—GPCR ligand binding—DRD4—conduct disorder	0.000182	0.002	CbGpPWpGaD
Thioproperazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000181	0.00199	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.00018	0.00198	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000178	0.00196	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.000178	0.00196	CbGpPWpGaD
Thioproperazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000172	0.00189	CbGpPWpGaD
Thioproperazine—DRD2—Signaling by GPCR—CGA—conduct disorder	0.00017	0.00187	CbGpPWpGaD
Thioproperazine—ALB—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00017	0.00186	CbGpPWpGaD
Thioproperazine—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000167	0.00184	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling by GPCR—CGA—conduct disorder	0.000167	0.00184	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	0.000163	0.0018	CbGpPWpGaD
Thioproperazine—DRD1—GPCR ligand binding—HTR2A—conduct disorder	0.00016	0.00176	CbGpPWpGaD
Thioproperazine—DRD1—Circadian rythm related genes—EP300—conduct disorder	0.000159	0.00174	CbGpPWpGaD
Thioproperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000159	0.00174	CbGpPWpGaD
Thioproperazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000153	0.00168	CbGpPWpGaD
Thioproperazine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000144	0.00159	CbGpPWpGaD
Thioproperazine—DRD1—GPCR downstream signaling—DRD4—conduct disorder	0.000139	0.00152	CbGpPWpGaD
Thioproperazine—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	0.000138	0.00151	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—CGA—conduct disorder	0.000133	0.00146	CbGpPWpGaD
Thioproperazine—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	0.000131	0.00144	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—CGA—conduct disorder	0.000127	0.00139	CbGpPWpGaD
Thioproperazine—DRD1—Signaling by GPCR—DRD4—conduct disorder	0.000126	0.00138	CbGpPWpGaD
Thioproperazine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	0.000121	0.00133	CbGpPWpGaD
Thioproperazine—DRD2—Circadian rythm related genes—EP300—conduct disorder	0.00012	0.00132	CbGpPWpGaD
Thioproperazine—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	0.000119	0.00131	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	0.000116	0.00128	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—CGA—conduct disorder	0.000114	0.00126	CbGpPWpGaD
Thioproperazine—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	0.000113	0.00125	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—CGA—conduct disorder	0.000109	0.0012	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling by GPCR—DRD4—conduct disorder	0.000108	0.00119	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—WASF1—conduct disorder	0.000106	0.00117	CbGpPWpGaD
Thioproperazine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	0.000105	0.00115	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	0.000103	0.00113	CbGpPWpGaD
Thioproperazine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	0.000103	0.00113	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	0.000101	0.00111	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—CGA—conduct disorder	0.0001	0.0011	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—CGA—conduct disorder	9.86e-05	0.00108	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—CGA—conduct disorder	9.66e-05	0.00106	CbGpPWpGaD
Thioproperazine—DRD2—Signaling by GPCR—DRD4—conduct disorder	9.5e-05	0.00104	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	9.35e-05	0.00103	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	9.15e-05	0.00101	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—WASF1—conduct disorder	9.15e-05	0.00101	CbGpPWpGaD
Thioproperazine—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	9.04e-05	0.000994	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—WASF1—conduct disorder	8.71e-05	0.000958	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—CGA—conduct disorder	8.47e-05	0.000931	CbGpPWpGaD
Thioproperazine—DRD1—Signaling by GPCR—HTR2A—conduct disorder	8.21e-05	0.000903	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—WASF1—conduct disorder	8.03e-05	0.000883	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—WASF1—conduct disorder	7.9e-05	0.000869	CbGpPWpGaD
Thioproperazine—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	7.77e-05	0.000855	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	7.74e-05	0.000851	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—DRD4—conduct disorder	7.43e-05	0.000817	CbGpPWpGaD
Thioproperazine—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	7.4e-05	0.000814	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	7.06e-05	0.000776	CbGpPWpGaD
Thioproperazine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	6.83e-05	0.000751	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	6.72e-05	0.000739	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	6.58e-05	0.000723	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—DRD4—conduct disorder	6.39e-05	0.000703	CbGpPWpGaD
Thioproperazine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	6.2e-05	0.000682	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—DRD4—conduct disorder	6.09e-05	0.000669	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	5.97e-05	0.000657	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—COMT—conduct disorder	5.71e-05	0.000628	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—MAOA—conduct disorder	5.67e-05	0.000624	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—DRD4—conduct disorder	5.61e-05	0.000617	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—DRD4—conduct disorder	5.52e-05	0.000607	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	5.41e-05	0.000595	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—HTR2A—conduct disorder	4.85e-05	0.000533	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—HTR2A—conduct disorder	4.17e-05	0.000459	CbGpPWpGaD
Thioproperazine—ALB—Hemostasis—EP300—conduct disorder	4.04e-05	0.000445	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	3.97e-05	0.000437	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—COMT—conduct disorder	3.82e-05	0.00042	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—MAOA—conduct disorder	3.8e-05	0.000417	CbGpPWpGaD
Thioproperazine—ALB—Metabolism of lipids and lipoproteins—EP300—conduct disorder	3.68e-05	0.000405	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—HTR2A—conduct disorder	3.66e-05	0.000403	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	3.53e-05	0.000388	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—EP300—conduct disorder	2.57e-05	0.000283	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—EP300—conduct disorder	2.45e-05	0.000269	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—EP300—conduct disorder	2.21e-05	0.000243	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—EP300—conduct disorder	2.1e-05	0.000231	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—EP300—conduct disorder	1.94e-05	0.000213	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—EP300—conduct disorder	1.91e-05	0.00021	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—EP300—conduct disorder	1.87e-05	0.000206	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—EP300—conduct disorder	1.64e-05	0.00018	CbGpPWpGaD
